Gene · 11346
Papers1,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Increased levels of antibodies to synaptopodin and annexin 1 in patients with primary podocytopathies. | Front Nephrol | 2024 | 39544697 | PubTator, text mining | PubMed |
| Mechanosensitive Differentiation of Human iPS Cell-Derived Podocytes. | Bioengineering (Basel) | 2024 | 39451413 | PubTator, text mining | PubMed |
| Effects of Inonotus obliquus on ameliorating podocyte injury in ORG mice through TNF pathway and prediction of active compounds. | Front Pharmacol | 2024 | 39234117 | PubTator, text mining | PubMed |
| Podocyte cell-specific Npr1 is required for blood pressure and renal homeostasis in male and female mice: role of sex-specific differences. | Physiol Genomics | 2024 | 39101921 | PubTator, text mining | PubMed |
| The Immunosuppressive Drug LF15-0195 Acts Also on Glomerular Lesions, by a Change in Cytoskeleton Distribution in Podocyte. | Am J Nephrol | 2024 | 39074452 | PubTator, text mining | PubMed |
| Association of the podocyte phenotype with extracapillary hypercellularity in patients with diabetic kidney disease. | J Nephrol | 2024 | 39066994 | PubTator, text mining | PubMed |
| Maintenance of Lognormal-Like Skewed Dendritic Spine Size Distributions in Dentate Granule Cells of TNF, TNF-R1, TNF-R2, and TNF-R1/2-Deficient Mice. | J Comp Neurol | 2024 | 38943486 | PubTator, text mining | PubMed |
| Deletion of IRE1α in podocytes exacerbates diabetic nephropathy in mice. | Sci Rep | 2024 | 38778209 | PubTator, text mining | PubMed |
| Synaptic Protein Loss in Extracellular Vesicles Reflects Brain and Retinal Atrophy in People With Multiple Sclerosis. | Neurol Neuroimmunol Neuroinflamm | 2024 | 38754047 | PubTator, text mining | PubMed |
| Mitochondrial DNA and Inflammation Are Associated with Cerebral Vessel Remodeling and Early Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus. | Biomolecules | 2024 | 38672515 | PubTator, text mining | PubMed |
| Novel immune cross-talk between inflammatory bowel disease and IgA nephropathy. | Ren Fail | 2024 | 38628140 | PubTator, text mining | PubMed |
| [Jianpi Zishen granule inhibits podocyte autophagy in systemic lupus erythematosus: a network pharmacology and clinical study]. | Nan Fang Yi Ke Da Xue Xue Bao | 2024 | 38597437 | PubTator, text mining | PubMed |
| A new index for the outcome of focal segmental glomerulosclerosis. | Sci Rep | 2024 | 38594302 | PubTator, text mining | PubMed |
| Synaptopodin is required for long-term depression at Schaffer collateral-CA1 synapses. | Mol Brain | 2024 | 38566234 | PubTator, text mining | PubMed |
| The redox-sensitive GSK3β is a key regulator of glomerular podocyte injury in type 2 diabetic kidney disease. | Redox Biol | 2024 | 38527400 | PubTator, text mining | PubMed |
| Hepatitis B virus-targeting sodium taurocholate cotransporting polypeptide mediates HBV infection and damage in human renal podocytes. | Microbiol Spectr | 2024 | 38315030 | PubTator, text mining | PubMed |
| Fetal and Placental Causes of Elevated Serum Alpha-Fetoprotein Levels in Pregnant Women. | J Clin Med | 2024 | 38256600 | PubTator, text mining | PubMed |
| Evaluating the State of Glomerular Disease by Analyzing Urinary Sediments: mRNA Levels and Immunofluorescence Staining for Various Markers. | Int J Mol Sci | 2024 | 38255818 | PubTator, text mining | PubMed |
| Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome. | Biomedicines | 2024 | 38255234 | PubTator, text mining | PubMed |
| Synaptopodin Regulates Denervation-Induced Plasticity at Hippocampal Mossy Fiber Synapses. | Cells | 2024 | 38247806 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11346/papers?page=4